Senior Regulatory Affairs Executive
Purapharm Corporation Limited
- Company Industries:Medical/Pharmaceutical
Job Information
- Post Date:2019-05-15
- Career Level:Entry Level
- Location:Tai Po Area
- Yr(s) of Exp:4 years
- Qualification:Degree
- Salary:Salary negotiable
- Employment Type:Full Time, Permanent
- Job Function:Pharmaceutical
- Benefits:Education allowance, Five-day work week, Life insurance, Medical insurance, Performance bonus
Job Description
Job Descriptions
- Responsible for world-wide pharmaceutical regulation research
負責研究各個地區的藥物規管要求 - Provide inputs on product master formula and ingredients adjustment as per country regulatory requirement
根據各地區的藥物規管要求,調整產品的成分及配方 - To ensure the product can be launched to the market as food in project early stage
確保項目內的產品在初期能以食品名義註冊,順利快速進入市場 - Assist R&D officer to draft and finalize clinical trial protocol
協助官能實驗研究員根據各地的藥物規管要求制定臨床實驗計劃
Job Requirements
- Degree in Pharmaceutical Science, Pharmacy or Pharmacy in Chinese Medicine
藥學專業本科以上 - Minimum 4 years’ experience with good understanding in pharmaceutical regulatory affairs as well as the corresponding definition of health supplements, food and pharmaceuticals
四年以上經驗,對藥物規管的技術和法律要求有一定的了解。對目標市場保健品、食品及藥品的相關定義有一定了解
Working Location: Hong Kong Science Park, Tai Po, N.T.
We offer 5-day working week and an attractive remuneration package. Interest parties please click “APPLY NOW”. For company details, please visit www.purapharm.com.
Our company is an equal opportunity employer. All personal data collected will be used for recruitment purpose only, while the personal data of the unsuccessful applicants will be destroyed within 6 months after the recruitment process.
Company Info
PuraPharm Corporation Limited (HKEx Stock Code: 1498) is a leading Hong Kong-based Chinese medicine company primarily engaged in the research and development, production, marketing and sale of concentrated Chinese Medicine granules (CCMG) products which we market under our brand “Nong’s® (農本方)”. We are the only CFDA-licensed CCMG product manufacturer in Hong Kong, qualified to issue safety reports recognized by over 70 countries around the world through our in-house CNAS ISO 17025 laboratory, in accordance to the CNAS standards. PuraPharm, the official supplier of CCMG to Hong Kong’s hospitals and healthcare institutions, has been supplying CCMG to the majority of hospitals in Hong Kong since 2004, and is now the leading and the largest supplier of CCMG products in Hong Kong with a market share of 70%.
Position | Company | Location | Update |
---|